Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, MD, Aneel Paulus, MD, Victoria R. Alegria, Betsy Laplant, MS, Muhamad Alhaj Moustafa, MD, Dustin Chapin, Keisha Jackson, Prachi Jani, MD, Salman Ahmed, MD, Brett Edwards, Alak Manna, PhD, Vivek Roy, MD, Taimur Sher, MD, Asher A. Chanan-Khan, MD

Blood (2019) 134 (Supplement_1): 1912.

https://doi.org/10.1182/blood-2019-128233

Published: 2019

Journal Articles

Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis

Vivek Kumar, MD, M.B.,B.S., Mays F Abdulazeez, BMSC, Suman Biswas, MD, Sri Lekha Bodepudi, Vivek Roy, MD, Taimur Sher, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Salman Ahmed, MD, Prachi Jani, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2019) 134 (Supplement_1): 71.

https://doi.org/10.1182/blood-2019-124799

Published: 2019

Journal Articles

Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, MD, Victoria R. Alegria, Salman Ahmed, MD, Betsy Laplant, MS, Alak Manna, PhD, Ricardo Parrondo, MD, Vivek Roy, MD, Taimur Sher, MD, Brett Edwards, Stephanie Lanier, Keisha Jackson, Asher A. Chanan-Khan, MD, Aneel Paulus, MD

Blood (2019) 134 (Supplement_1): 3137.

https://doi.org/10.1182/blood-2019-128610

Published: 2019

Journal Articles

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Madiha Iqbal, MBBS, Aaron C. Spaulding, Chanel Wood, Salman Ahmed, MD, Prachi Jani, MD, Rami Manochakian, MD, Aneel Paulus, MD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD, Sikander Ailawadhi, Asher A. Chanan-Khan, MD, Shehzad Niazi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4852.

https://doi.org/10.1182/blood-2018-99-119912

Published: 2018

Journal Articles

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Leyla Bojanini, MD, Prakash Vishnu, MD, Vivek Roy, MD, Rami Manochakian, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Salman Ahmed, MD, Prachi Jani, MD, Victoria R. Alegria, Meghna Ailawadhi, MD, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4764.

https://doi.org/10.1182/blood-2018-99-120127

Published: 2018

Journal Articles

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Prakash Vishnu, MD, Vivek Roy, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Salman Ahmed, MD, Prachi Jani, MD, Zan Tahir Shareef, Sri Lekha Bodepudi, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4765.

https://doi.org/10.1182/blood-2018-99-119981

Published: 2018

Journal Articles

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Sikander Ailawadhi, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Shishir David, Vivek Roy, MD, Aneel Paulus, MD, Victoria R. Alegria, Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Prakash Vishnu, MD, Sonikpreet Aulakh, MD, Rami Manochakian, MD, Asher A. Chanan-Khan, MD, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4861.

https://doi.org/10.1182/blood-2018-99-117155

Published: 2018

Journal Articles

Sociodemographic Profile and Outcomes of Patients with Non-Diffuse Large B-Cell Lymphoma (non-DLBCL) Treated at Minority-Predominant Facilities in the United States

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4868.

https://doi.org/10.1182/blood-2018-99-119976

Published: 2018

Journal Articles

Exploring Disease Biology in Hispanic Versus Non-Hispanic Patients with Diffuse Large B-Cell Lymphoma (DLBCL) to Explain Survival Disparities

Sikander Ailawadhi, Alvaro J. Alencar, MD, Madiha Iqbal, MBBS, Prachi Jani, MD, Salman Ahmed, MD, Aditya Mehta, Ruqin Chen, MD, Leyla Bojanini, MD, Moises Harari Turquie, MD, Kevin R Kelly, MD PhD, Prakash Vishnu, MD, Vivek Roy, MD, Anshika Singh, Abuzar Asif, Shishir David, Imran Siddiqi, MD PhD, Asher A. Chanan-Khan, MD, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4867.

https://doi.org/10.1182/blood-2018-99-119494

Published: 2018

Journal Articles

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Madiha Iqbal, MBBS, Aaron C. Spaulding, Salman Ahmed, MD, Prachi Jani, MD, Chanel Wood, Shehzad Niazi, Rami Manochakian, MD, Aneel Paulus, MD, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Vivek Roy, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 5873.

https://doi.org/10.1182/blood-2018-99-119781

Published: 2018

Journal Articles

Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome

Aneel Paulus, MD, Prachi Jani, MD, Salman Ahmed, MD, Sonikpreet Aulakh, MD, Alak Manna, PhD, Neeraj Kumar Singh, B.Tech, Mohammed Sauban, B.E, Zakir Husain, M.Tech, Ansu Kumar, M.Sc., Pallavi Kumari, M.Sc., Anuj Tyagi, M.Sc., Taimur Sher, MD, Rami Manochakian, MD, Vivek Roy, MD, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 1911.

https://doi.org/10.1182/blood-2018-99-119574

Published: 2018

NARROW

Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis

Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Sociodemographic Profile and Outcomes of Patients with Non-Diffuse Large B-Cell Lymphoma (non-DLBCL) Treated at Minority-Predominant Facilities in the United States

Exploring Disease Biology in Hispanic Versus Non-Hispanic Patients with Diffuse Large B-Cell Lymphoma (DLBCL) to Explain Survival Disparities

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only